Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2019 Filed Mar 18, 2019 12:15 UTC |
Burke Steven KeithSVP and Chief Medical Officer
|
GiftCommon Stock | 7,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-19-001780 · ownership.xml · nonDerivative · entry 5 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 26,332 F3 · kind: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F3 · shares: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F3 · ownership.nature: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 15, 2019 Filed Mar 18, 2019 12:15 UTC |
Burke Steven KeithSVP and Chief Medical Officer
|
GiftCommon Stock | 7,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-19-001780 · ownership.xml · nonDerivative · entry 4 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 18,999 F2 · kind: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F2 · shares: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F2 · ownership.nature: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 15, 2019 Filed Mar 18, 2019 12:15 UTC |
Burke Steven KeithSVP and Chief Medical Officer
|
GiftCommon Stock | 7,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-19-001780 · ownership.xml · nonDerivative · entry 3 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,917 F3 · kind: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F3 · shares: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 15, 2019 Filed Mar 18, 2019 12:15 UTC |
Burke Steven KeithSVP and Chief Medical Officer
|
GiftCommon Stock | 7,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-19-001780 · ownership.xml · nonDerivative · entry 2 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,251 F2 · kind: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F2 · shares: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| March 15, 2019 Filed Mar 18, 2019 12:15 UTC |
Burke Steven KeithSVP and Chief Medical Officer
|
GiftCommon Stock | 7,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-19-001780 · ownership.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,584 F1 · kind: This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F1 · shares: This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| January 31, 2019 Filed Feb 4, 2019 08:00 UTC |
NOYES TIMOTHY PDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 350,000 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0001171843-19-000681 · ownership.xml · derivative · entry 1 NOYES TIMOTHY P · CIK 0001185035 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock, $0.001 par value · 350,000 shares Expires 2029-01-30 F1 · derivative.exercise_date: The options were granted on January 31, 2019 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 21:20 UTC |
Gottlieb Daniel PhilipVP Corporate Development
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $2.64 | $0.00 |
DisclosureSEC source: 0001171843-19-000440 · ownership.xml · derivative · entry 1 Gottlieb Daniel Philip · CIK 0001619811 · VP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock, $0.001 par value · 60,000 shares Expires 2029-01-17 F1 · derivative.exercise_date: The options were granted on January 18, 2019 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 21:20 UTC |
Toner E. ScottSenior VP of Commercial
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $2.64 | $0.00 |
DisclosureSEC source: 0001171843-19-000439 · ownership.xml · derivative · entry 1 Toner E. Scott · CIK 0001643772 · Senior VP of Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock, $0.001 par value · 60,000 shares Expires 2029-01-17 F1 · derivative.exercise_date: The options were granted on January 18, 2019 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 21:19 UTC |
Kowalsky Matthew PaulVP, Legal and Secretary
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $2.64 | $0.00 |
DisclosureSEC source: 0001171843-19-000438 · ownership.xml · derivative · entry 1 Kowalsky Matthew Paul · CIK 0001705824 · VP, Legal and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock, $0.001 par value · 60,000 shares Expires 2029-01-17 F1 · derivative.exercise_date: The options were granted on January 18, 2019 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 21:19 UTC |
Hartman Bradley JVP, People
|
GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $2.64 | $0.00 |
DisclosureSEC source: 0001171843-19-000437 · ownership.xml · derivative · entry 1 Hartman Bradley J · CIK 0001748625 · VP, People 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock, $0.001 par value · 70,000 shares Expires 2029-01-17 F1 · derivative.exercise_date: The options were granted on January 18, 2019 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 21:18 UTC |
Eldridge, George ArthurSr VP, CFO, Treasr, Asst Secy
|
GrantStock Option (Right to Buy) · Derivative | 145,000 | $0.00 Strike: $2.64 | $0.00 |
DisclosureSEC source: 0001171843-19-000436 · ownership.xml · derivative · entry 1 Eldridge, George Arthur · CIK 0001622905 · Sr VP, CFO, Treasr, Asst Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,000 Underlying: Common Stock, $0.001 par value · 145,000 shares Expires 2029-01-17 F1 · derivative.exercise_date: The options were granted on January 18, 2019 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 21:17 UTC |
Burke Steven KeithSVP and Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 145,000 | $0.00 Strike: $2.64 | $0.00 |
DisclosureSEC source: 0001171843-19-000435 · ownership.xml · derivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,000 Underlying: Common Stock, $0.001 par value · 145,000 shares Expires 2029-01-17 F1 · derivative.exercise_date: The options were granted on January 18, 2019 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 13:20 UTC |
Toner E. ScottSenior VP of Commercial
|
GrantCommon Stock | 4,117 | $1.93 | $7,945.81 |
DisclosureSEC source: 0001171843-19-000066 · ownership.xml · nonDerivative · entry 1 Toner E. Scott · CIK 0001643772 · Senior VP of Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,357 F1 · kind: The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of July 1, 2018 through December 31, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 13:19 UTC |
Kowalsky Matthew PaulVP, Legal and Secretary
|
GrantCommon Stock | 2,448 | $1.93 | $4,724.64 |
DisclosureSEC source: 0001171843-19-000065 · ownership.xml · nonDerivative · entry 1 Kowalsky Matthew Paul · CIK 0001705824 · VP, Legal and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,479 F1 · kind: The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of July 1, 2018 through December 31, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 13:19 UTC |
Eldridge, George ArthurSr VP, CFO, Treasr, Asst Secy
|
GrantCommon Stock | 2,448 | $1.93 | $4,724.64 |
DisclosureSEC source: 0001171843-19-000064 · ownership.xml · nonDerivative · entry 1 Eldridge, George Arthur · CIK 0001622905 · Sr VP, CFO, Treasr, Asst Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,132 F1 · kind: The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of July 1, 2018 through December 31, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 13:19 UTC |
Burke Steven KeithSVP and Chief Medical Officer
|
GrantCommon Stock | 2,448 | $1.93 | $4,724.64 |
DisclosureSEC source: 0001171843-19-000063 · ownership.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,917 F1 · kind: The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of July 1, 2018 through December 31, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 20:20 UTC |
Hartman Bradley JVP, People
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $2.13 | $0.00 |
DisclosureSEC source: 0001171843-18-005699 · ownership.xml · derivative · entry 1 Hartman Bradley J · CIK 0001748625 · VP, People 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock, $0.001 par value · 150,000 shares Expires 2028-07-31 F1 · derivative.exercise_date: The options were granted on August 1, 2018 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 12:24 UTC |
Toner E. ScottSenior VP of Commercial
|
GrantCommon Stock | 4,856 | $1.62 | $7,842.44 |
DisclosureSEC source: 0001171843-18-004991 · ownership.xml · nonDerivative · entry 1 Toner E. Scott · CIK 0001643772 · Senior VP of Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,240 F1 · kind: The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of January 1, 2018 through June 30, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 12:20 UTC |
Kowalsky Matthew PaulVP, Legal and Secretary
|
GrantCommon Stock | 10,000 | $1.62 | $16,150.00 |
DisclosureSEC source: 0001171843-18-004990 · ownership.xml · nonDerivative · entry 1 Kowalsky Matthew Paul · CIK 0001705824 · VP, Legal and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,031 F1 · kind: The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of January 1, 2018 through June 30, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 12:19 UTC |
Eldridge, George ArthurSr VP, CFO, Treasr, Asst Secy
|
GrantCommon Stock | 10,000 | $1.62 | $16,150.00 |
DisclosureSEC source: 0001171843-18-004989 · ownership.xml · nonDerivative · entry 1 Eldridge, George Arthur · CIK 0001622905 · Sr VP, CFO, Treasr, Asst Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,684 F1 · kind: The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of January 1, 2018 through June 30, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 12:19 UTC |
Burke Steven KeithSVP and Chief Medical Officer
|
GrantCommon Stock | 10,000 | $1.62 | $16,150.00 |
DisclosureSEC source: 0001171843-18-004988 · formfour.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,469 F1 · kind: The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of January 1, 2018 through June 30, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 08, 2018 Filed Jun 11, 2018 20:32 UTC |
Freund John GordonDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,700 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001171843-18-004580 · formfour.xml · derivative · entry 1 Freund John Gordon · CIK 0001296771 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,700 Underlying: Common Stock · 12,700 shares Expires 2028-06-07 F1 · derivative.exercise_date: The options were granted on June 8, 2018 and the shares underlying this option will vest 100% at the earlier of (i) June 8, 2019 and (ii) the Issuer's next annual meeting of stockholders. Read SEC document |
| June 08, 2018 Filed Jun 11, 2018 20:31 UTC |
BOHLIN GAREN GDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,700 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001171843-18-004578 · formfour.xml · derivative · entry 1 BOHLIN GAREN G · CIK 0001254705 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,700 Underlying: Common Stock · 12,700 shares Expires 2028-06-07 F1 · derivative.exercise_date: The options were granted on June 8, 2018 and the shares underlying this option will vest 100% at the earlier of (i) June 8, 2019 and (ii) the Issuer's next annual meeting of stockholders. Read SEC document |
| June 08, 2018 Filed Jun 11, 2018 16:31 UTC |
Canute Scott ADirector
|
GrantStock Option (Right to Buy) · Derivative | 12,700 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001171843-18-004579 · formfour.xml · derivative · entry 1 Canute Scott A · CIK 0001303416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,700 Underlying: Common Stock · 12,700 shares Expires 2028-06-07 F1 · derivative.exercise_date: The options were granted on June 8, 2018 and the shares underlying this option will vest 100% at the earlier of (i) June 8, 2019 and (ii) the Issuer's next annual meeting of stockholders. Read SEC document |
| June 08, 2018 Filed Jun 11, 2018 20:33 UTC |
HASTINGS PAUL JDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,700 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001171843-18-004582 · formfour.xml · derivative · entry 1 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,700 Underlying: Common Stock · 12,700 shares Expires 2028-06-07 F1 · derivative.exercise_date: The options were granted on June 8, 2018 and the shares underlying this option will vest 100% at the earlier of (i) June 8, 2019 and (ii) the Issuer's next annual meeting of stockholders. Read SEC document |
| June 08, 2018 Filed Jun 11, 2018 20:34 UTC |
Kingsley Stuart ADirector
|
GrantStock Option (Right to Buy) · Derivative | 12,700 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001171843-18-004583 · formfour.xml · derivative · entry 1 Kingsley Stuart A · CIK 0001369067 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,700 Underlying: Common Stock · 12,700 shares Expires 2028-06-07 F1 · derivative.exercise_date: The options were granted on June 8, 2018 and the shares underlying this option will vest 100% at the earlier of (i) June 8, 2019 and (ii) the Issuer's next annual meeting of stockholders. Read SEC document |
| June 08, 2018 Filed Jun 11, 2018 20:33 UTC |
Haines TimothyDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 12,700 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001171843-18-004581 · formfour.xml · derivative · entry 1 Haines Timothy · CIK 0001526068 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,700 Underlying: Common Stock · 12,700 shares Expires 2028-06-07 F1 · derivative.exercise_date: Tim Haines (the "Reporting Person") was granted options to purchase shares of common stock in consideration of his services as a director of the Issuer (the "Options"). The Options were granted on June 8, 2018 and the shares underlying the Options will vest 100% at the earlier of (i) June 8, 2019 and (ii) the Issuer's next annual meeting of stockholders. F2 · ownership.direct: The Reporting Person is a member of Abingworth LLP ("ALLP"). ALLP provides advisory services to Abingworth Bioventures VI, LP ("ABV VI"). Under an agreement between the Reporting Person and ALLP, the Reporting Person is deemed to hold the Options and any shares of common stock issuable upon exercise of the Options, for the benefit of ABV VI, and must exercise the Options solely upon the direction of ALLP. F3 · ownership.direct: ABV VI may be deemed the indirect beneficial owner of the Options, and the Reporting Person may be deemed the indirect beneficial owner of the Options through his indirect interest in ABV VI. The Reporting Person disclaims beneficial ownership of the Options except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person, ALLP, ABV VI or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| June 08, 2018 Filed Jun 11, 2018 20:31 UTC |
Birner HubertDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 12,700 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001171843-18-004577 · formfour.xml · derivative · entry 1 Birner Hubert · CIK 0001398598 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,700 Underlying: Common Stock · 12,700 shares Expires 2028-06-07 F1 · derivative.exercise_date: The options were granted on June 8, 2018 and the shares underlying this option will vest 100% at the earlier of (i) June 8, 2019 and (ii) the Issuer's next annual meeting of stockholders. Read SEC document |
| June 08, 2018 Filed Jun 11, 2018 20:30 UTC |
Abingworth LLP10% owner
|
GrantStock Option (Right to Buy) · Derivative | 12,700 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001171843-18-004576 · formfour.xml · derivative · entry 1 Abingworth LLP · CIK 0001397144 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By affiliate Disclosed balance after: 12,700 Underlying: Common Stock · 12,700 shares Expires 2028-06-07 F2 · derivative.exercise_date: The options were granted on June 8, 2018 and the shares underlying this option will vest 100% at the earlier of (i) June 8, 2019 and (ii) the Issuer's next annual meeting of stockholders. F1 · ownership.direct: These options (the "Options") were granted to Tim Haines ("Haines"), a member of Abingworth LLP ("ALLP"). ALLP provides advisory services to Abingworth Bioventures VI, LP ("ABV VI"). Under an agreement between Haines and ALLP, Haines is deemed to hold the Options and any shares of common stock issuable upon exercise of the Options for the benefit of ABV VI, and must exercise the Options solely upon the direction of ALLP. F3 · ownership.direct: ABV VI may be deemed the indirect beneficial owner of the Options, and Haines may be deemed the indirect beneficial owner of the Options through his indirect interest in ABV VI. ALLP disclaims beneficial ownership of the Options except to the extent, if any, of its pecuniary interest therein. This report shall not be deemed an admission that ALLP, ABV VI, Haines or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. F1 · ownership.nature: These options (the "Options") were granted to Tim Haines ("Haines"), a member of Abingworth LLP ("ALLP"). ALLP provides advisory services to Abingworth Bioventures VI, LP ("ABV VI"). Under an agreement between Haines and ALLP, Haines is deemed to hold the Options and any shares of common stock issuable upon exercise of the Options for the benefit of ABV VI, and must exercise the Options solely upon the direction of ALLP. F3 · ownership.nature: ABV VI may be deemed the indirect beneficial owner of the Options, and Haines may be deemed the indirect beneficial owner of the Options through his indirect interest in ABV VI. ALLP disclaims beneficial ownership of the Options except to the extent, if any, of its pecuniary interest therein. This report shall not be deemed an admission that ALLP, ABV VI, Haines or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 18:43 UTC |
Flynn James EDirector · *Director by Deputization
DEERFIELD MANAGEMENT COMPANY, L.P.Director · *Director by Deputization
|
GrantStock Option (Right to Buy) · Derivative | 12,700 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001193805-18-000827 · e618092_4-proteon.xml · derivative · entry 1 Flynn James E · CIK 0001352546 · Director · *Director by Deputization DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) · CIK 0001009258 · Director · *Director by Deputization Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Through Deerfield Management Company, L.P. Disclosed balance after: 12,700 Underlying: Common Stock · 12,700 shares Expires 2028-06-07 F1 · shares: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management"). F2 · derivative.exercise_date: The option shall vest and become exercisable with respect to 100% of the shares on the earlier of (i) June 8, 2019 and (ii) the next annual meeting of stockholders of the Issuer. F1 · derivative.underlying_shares: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management"). F1 · balance_after: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management"). F1 · ownership.nature: Jonathan S. Leff, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The option granted to Jonathan S. Leff and reported herein is held for the benefit, and at the direction, of Deerfield Management Company, L.P. ("Deerfield Management"). F3 · ownership.nature: This Form 4 is being filed by the undersigned as well as the entity listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). James E. Flynn is the sole member of the general partner of Deerfield Management Company, L.P. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 18:45 UTC |
LEFF JONATHAN SDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,700 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001193805-18-000828 · e618093_4-proteon.xml · derivative · entry 1 LEFF JONATHAN S · CIK 0001215242 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,700 Underlying: Common Stock · 12,700 shares Expires 2028-06-07 F1 · shares: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the option for the benefit, and at the direction, of Deerfield Management Company, L.P. F2 · derivative.exercise_date: The option shall vest and become exercisable with respect to 100% of the shares on the earlier of (i) June 8, 2019 and (ii) the next annual meeting of stockholders of the Issuer. F1 · derivative.underlying_shares: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the option for the benefit, and at the direction, of Deerfield Management Company, L.P. F1 · balance_after: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the option for the benefit, and at the direction, of Deerfield Management Company, L.P. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 08:15 UTC |
NOYES TIMOTHY PDirector · President and CEO
|
Disposition to issuerCommon Stock | 2,997 | $2.11 | $6,323.67 |
DisclosureSEC source: 0001171843-18-001229 · formfour.xml · nonDerivative · entry 1 NOYES TIMOTHY P · CIK 0001185035 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017. F2 · price: The selling price of $2.11 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $2.10 to $2.15. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 15, 2018 Filed Feb 16, 2018 08:15 UTC |
NOYES TIMOTHY PDirector · President and CEO
|
Disposition to issuerCommon Stock | 2,245 | $2.15 | $4,831.24 |
DisclosureSEC source: 0001171843-18-001197 · f4_noyes021618.xml · nonDerivative · entry 2 NOYES TIMOTHY P · CIK 0001185035 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,997 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017. F3 · price: The selling price of $2.152 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $2.10 to $2.25. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 08:15 UTC |
NOYES TIMOTHY PDirector · President and CEO
|
Disposition to issuerCommon Stock | 3,500 | $2.20 | $7,700.00 |
DisclosureSEC source: 0001171843-18-001197 · f4_noyes021618.xml · nonDerivative · entry 1 NOYES TIMOTHY P · CIK 0001185035 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,242 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017. F2 · price: The selling price of $2.20 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $2.20 to $2.23. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 08, 2018 Filed Feb 9, 2018 08:16 UTC |
NOYES TIMOTHY PDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001171843-18-001001 · formfour.xml · derivative · entry 1 NOYES TIMOTHY P · CIK 0001185035 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock, $0.001 par value · 500,000 shares Expires 2028-02-07 F1 · derivative.exercise_date: The options were granted on February 8, 2018 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments. Read SEC document |
| January 17, 2018 Filed Jan 18, 2018 22:17 UTC |
Toner E. ScottSenior VP of Commercial
|
GrantStock Option (Right to Buy) · Derivative | 110,000 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001171843-18-000444 · formfour.xml · derivative · entry 1 Toner E. Scott · CIK 0001643772 · Senior VP of Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock, $0.001 par value · 110,000 shares Expires 2028-01-16 F1 · derivative.exercise_date: The options were granted on January 17, 2018 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments. Read SEC document |
| January 17, 2018 Filed Jan 18, 2018 22:17 UTC |
Kowalsky Matthew PaulVP, Legal and Secretary
|
GrantStock Option (Right to Buy) · Derivative | 110,000 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001171843-18-000443 · f4_011818kowalsky.xml · derivative · entry 1 Kowalsky Matthew Paul · CIK 0001705824 · VP, Legal and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock, $0.001 par value · 110,000 shares Expires 2028-01-16 F1 · derivative.exercise_date: The options were granted on January 17, 2018 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments. Read SEC document |
| January 17, 2018 Filed Jan 18, 2018 22:17 UTC |
Gottlieb Daniel PhilipVP Corporate Development
|
GrantStock Option (Right to Buy) · Derivative | 110,000 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001171843-18-000442 · formfour.xml · derivative · entry 1 Gottlieb Daniel Philip · CIK 0001619811 · VP Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock, $0.001 par value · 110,000 shares Expires 2028-01-16 F1 · derivative.exercise_date: The options were granted on January 17, 2018 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments. Read SEC document |
| January 17, 2018 Filed Jan 18, 2018 22:16 UTC |
Eldridge, George ArthurSr VP, CFO, Treasr, Asst Secy
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001171843-18-000441 · formfour.xml · derivative · entry 1 Eldridge, George Arthur · CIK 0001622905 · Sr VP, CFO, Treasr, Asst Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock, $0.001 par value · 200,000 shares Expires 2028-01-16 F1 · derivative.exercise_date: The options were granted on January 17, 2018 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments. Read SEC document |
| January 17, 2018 Filed Jan 18, 2018 22:16 UTC |
Burke Steven KeithSVP and Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0001171843-18-000440 · formfour.xml · derivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock, $0.001 par value · 200,000 shares Expires 2028-01-16 F1 · derivative.exercise_date: The options were granted on January 17, 2018 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments. Read SEC document |
| January 16, 2018 Filed Jan 17, 2018 17:01 UTC |
NOYES TIMOTHY PDirector · President and CEO
|
Disposition to issuerCommon Stock | 10,000 | $2.36 | $23,570.00 |
DisclosureSEC source: 0001171843-18-000401 · formfour.xml · nonDerivative · entry 1 NOYES TIMOTHY P · CIK 0001185035 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,742 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2017. F2 · price: The selling price of $2.357 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $2.30 to $2.425. The reporting person undertakes to provide Proteon Therapeutics, Inc., any security holder of Proteon Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 13:17 UTC |
Toner E. ScottSenior VP of Marketing
|
GrantCommon Stock | 5,531 | $1.30 | $7,168.18 |
DisclosureSEC source: 0001171843-18-000084 · form4toner.xml · nonDerivative · entry 1 Toner E. Scott · CIK 0001643772 · Senior VP of Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,384 F1 · kind: The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of July 1, 2017 through December 31, 2017 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 13:16 UTC |
Kowalsky Matthew PaulVP, Legal and Secretary
|
GrantCommon Stock | 3,934 | $1.30 | $5,098.46 |
DisclosureSEC source: 0001171843-18-000083 · form4kowalsky.xml · nonDerivative · entry 1 Kowalsky Matthew Paul · CIK 0001705824 · VP, Legal and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,031 F1 · kind: The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of July 1, 2017 through December 31, 2017 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 13:16 UTC |
Eldridge, George ArthurSr VP, CFO, Treasr, Asst Secy
|
GrantCommon Stock | 3,934 | $1.30 | $5,098.46 |
DisclosureSEC source: 0001171843-18-000082 · form4eldridge.xml · nonDerivative · entry 1 Eldridge, George Arthur · CIK 0001622905 · Sr VP, CFO, Treasr, Asst Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,684 F1 · kind: The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of July 1, 2017 through December 31, 2017 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 13:15 UTC |
Burke Steven KeithSVP and Chief Medical Officer
|
GrantCommon Stock | 3,934 | $1.30 | $5,098.46 |
DisclosureSEC source: 0001171843-18-000081 · form4burke.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,469 F1 · kind: The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of July 1, 2017 through December 31, 2017 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 22:11 UTC |
Burke Steven KeithSVP and Chief Medical Officer
|
GiftCommon Stock | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-17-007734 · formfour.xml · nonDerivative · entry 6 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 11,666 F4 · kind: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F4 · shares: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F4 · ownership.nature: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 22:11 UTC |
Burke Steven KeithSVP and Chief Medical Officer
|
GiftCommon Stock | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-17-007734 · formfour.xml · nonDerivative · entry 5 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 8,333 F3 · kind: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F3 · shares: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F3 · ownership.nature: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 22:11 UTC |
Burke Steven KeithSVP and Chief Medical Officer
|
GiftCommon Stock | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-17-007734 · formfour.xml · nonDerivative · entry 4 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,535 F4 · kind: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F4 · shares: This transaction involved a gift of securities by the reporting person to the Steven Edward Burke Irrevocable Trust u/a 11/15/2000, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 22:11 UTC |
Burke Steven KeithSVP and Chief Medical Officer
|
GiftCommon Stock | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-17-007734 · formfour.xml · nonDerivative · entry 3 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,868 F3 · kind: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F3 · shares: This transaction involved a gift of securities by the reporting person to the Timothy Andrew Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son, who is deemed to share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 22:11 UTC |
Burke Steven KeithSVP and Chief Medical Officer
|
GiftCommon Stock | 3,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-17-007734 · formfour.xml · nonDerivative · entry 2 Burke Steven Keith · CIK 0001619834 · SVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,201 F2 · kind: This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. F2 · shares: This transaction involved a gift of securities by the reporting person to the William Conroy Burke Irrevocable Trust u/a 12/28/1998, an irrevocable trust established by the reporting person for the benefit of his son. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.